Original source: https://www.investing.com/news/stock-market-news/eli-lilly-sees-2026-profit-above-estimates-on-weightloss-drug-demand-4484339
Lilly sees strong growth in 2026 as weight-loss drug rival Novo slips
Tweet on Twitter
Share on Facebook
Google+
Pinterest